Ähnliche Schlagwörter innerhalb Ihrer Suche.
Treffer 1 - 20 von 22 für Suche '"Complement Inactivating Agents"', Suchdauer: 1,58s Treffer weiter einschränken
  1. 1
    Sequential administration of anti-complement component C5 eculizumab and type-2 anti-CD20 obinutuzumab for the treatment of early antibody-mediated rejection after kidney transplantation A proof of concept
    von Favi, Evaldo
    Veröffentlicht in: Clinical immunology (Orlando, Fla.) (2024)
    Schlagworte: “...NLM Complement Inactivating Agents...”

    Online-Aufsatz

  2. 2
    RWC Update Removal of Subretinal Band Without Retinotomy; Geographic Atrophy: How Do You Select Appropriate Patients for Anti-Complement Therapy?; Shaken Baby Syndrome
    Schlagworte: “...NLM Complement Inactivating Agents...”

    Online-Aufsatz

  3. 3
    Complement Inhibitors for the Treatment of Geographic Atrophy
    Schlagworte: “...NLM Complement Inactivating Agents...”

    Online-Aufsatz

  4. 4
    Anti-C1s humanized monoclonal antibody SAR445088 A classical pathway complement inhibitor specific for the active form of C1s
    von Simmons, Ken T
    Veröffentlicht in: Clinical immunology (Orlando, Fla.) (2023)
    Schlagworte: “...NLM Complement Inactivating Agents...”

    Online-Aufsatz

  5. 5
    A nanobody-based complement inhibitor targeting complement component 2 reduces hemolysis in a complement humanized mouse model of autoimmune hemolytic anemia
    von Chen, Jin Y
    Veröffentlicht in: Clinical immunology (Orlando, Fla.) (2023)
    Schlagworte: “...NLM Complement Inactivating Agents...”

    Online-Aufsatz

  6. 6
    COVID-19 A review of therapeutic strategies and vaccine candidates
    von Izda, Vladislav
    Veröffentlicht in: Clinical immunology (Orlando, Fla.) (2021)
    Schlagworte: “...NLM Complement Inactivating Agents...”

    Online-Aufsatz

  7. 7
    Activation of classical and alternative complement pathways in the pathogenesis of lung injury in COVID-19
    von Satyam, Abhigyan
    Veröffentlicht in: Clinical immunology (Orlando, Fla.) (2021)
    Schlagworte: “...NLM Complement Inactivating Agents...”

    Online-Aufsatz

  8. 8
    Cellular changes in eculizumab early responders with generalized myasthenia gravis
    von Li, Yingkai
    Veröffentlicht in: Clinical immunology (Orlando, Fla.) (2021)
    Schlagworte: “...misc Complement inactivating agents...”

    Online-Aufsatz

  9. 9
    Commentary on "Complement C3 vs C5 inhibition in severe COVID-19 Early clinical findings reveal differential biological efficacy" by D.C. Mastellos et al
    Schlagworte: “...NLM Complement Inactivating Agents...”

    Online-Aufsatz

  10. 10
    Ex vivo assays to detect complement activation in complementopathies
    von Yuan, Xuan
    Veröffentlicht in: Clinical immunology (Orlando, Fla.) (2020)
    Schlagworte: “...NLM Complement Inactivating Agents...”

    Online-Aufsatz

  11. 11
    The first case of COVID-19 treated with the complement C3 inhibitor AMY-101
    von Mastaglio, Sara
    Veröffentlicht in: Clinical immunology (Orlando, Fla.) (2020)
    Schlagworte: “...NLM Complement Inactivating Agents...”

    Online-Aufsatz

  12. 12
    Complement C3 vs C5 inhibition in severe COVID-19 Early clinical findings reveal differential biological efficacy
    Schlagworte: “...NLM Complement Inactivating Agents...”

    Online-Aufsatz

  13. 13
    A plea for the pathogenic role of immune complexes in severe Covid-19
    Schlagworte: “...NLM Complement Inactivating Agents...”

    Online-Aufsatz

  14. 14
    Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19
    Schlagworte: “...NLM Complement Inactivating Agents...”

    Online-Aufsatz

  15. 15
    Taming hemodialysis-induced inflammation Are complement C3 inhibitors a viable option?
    Schlagworte: “...NLM Complement Inactivating Agents...”

    Online-Aufsatz

  16. 16
    Safety profile after prolonged C3 inhibition
    von Reis, Edimara S
    Veröffentlicht in: Clinical immunology (Orlando, Fla.) (2018)
    Schlagworte: “...NLM Complement Inactivating Agents...”

    Online-Aufsatz

  17. 17
    Recurrent allograft C3 glomerulonephritis and unsuccessful eculizumab treatment
    von Kaartinen, Kati
    Veröffentlicht in: Clinical immunology (Orlando, Fla.) (2018)
    Schlagworte: “...NLM Complement Inactivating Agents...”

    Online-Aufsatz

  18. 18
    Alternative complement pathway hemolytic assays reveal incomplete complement blockade in patients treated with eculizumab
    Schlagworte: “...NLM Complement Inactivating Agents...”

    Online-Aufsatz

  19. 19
    Sensitive, reliable and easy-performed laboratory monitoring of eculizumab therapy in atypical hemolytic uremic syndrome
    Schlagworte: “...NLM Complement Inactivating Agents...”

    Online-Aufsatz

  20. 20
    Comparison of Geographic Atrophy Growth Rates Using Different Imaging Modalities in the COMPLETE Study
    Schlagworte: “...NLM Complement Inactivating Agents...”

    Online-Aufsatz

Suchwerkzeuge: RSS-Feed abonnieren — Diese Suche als E-Mail versenden